Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. Gut Hsu, Y. C., Tseng, C. H., Su, T. H., Kao, J. H., Nguyen, M. H. 2021
View details for DOI 10.1136/gutjnl-2021-326232
View details for PubMedID 34670810